Key Points
- Astera Labs COO Sanjay Gajendra sold 280,000 shares on May 19 at an average price of $249.19, generating about $69.8 million. The sale reduced his ownership by 31.28% and was made under a pre-arranged Rule 10b5-1 plan.
- Gajendra had also sold additional shares earlier in May, including 95,444 shares on May 18 and two more sales on May 7. Altogether, the article highlights a series of insider transactions rather than a single isolated trade.
- Astera Labs remains a high-growth, highly valued stock after posting stronger-than-expected quarterly results, with EPS and revenue both beating estimates and revenue up 93.5% year over year. Despite the insider selling, analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target below the recent trading price.
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) COO Sanjay Gajendra sold 280,000 shares of the firm's stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $249.19, for a total transaction of $69,773,200.00. Following the completion of the sale, the chief operating officer owned 615,000 shares of the company's stock, valued at $153,251,850. This trade represents a 31.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Sanjay Gajendra also recently made the following trade(s):
- On Monday, May 18th, Sanjay Gajendra sold 95,444 shares of Astera Labs stock. The stock was sold at an average price of $225.02, for a total transaction of $21,476,808.88.
- On Thursday, May 7th, Sanjay Gajendra sold 49,361 shares of Astera Labs stock. The stock was sold at an average price of $199.21, for a total transaction of $9,833,204.81.
- On Thursday, May 7th, Sanjay Gajendra sold 230,639 shares of Astera Labs stock. The stock was sold at an average price of $198.22, for a total transaction of $45,717,262.58.
Astera Labs Price Performance
NASDAQ:ALAB opened at $297.84 on Friday. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $298.36. The company's 50-day simple moving average is $166.74 and its 200 day simple moving average is $158.75. The firm has a market capitalization of $51.05 billion, a P/E ratio of 201.24, a PEG ratio of 3.81 and a beta of 3.35.
Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the firm posted $0.33 earnings per share. Astera Labs's quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.
Key Stories Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Recent analyst coverage has been constructive, including multiple price-target increases and “buy” recommendations, which has helped extend momentum in ALAB shares.
- Positive Sentiment: Astera Labs has been drawing bullish trader attention, with elevated call option activity and a “Power Inflow” signal suggesting strong buying interest in the stock.
- Positive Sentiment: The company’s latest earnings beat expectations on both revenue and EPS, supporting the case that AI-related demand is translating into rapid growth.
- Neutral Sentiment: Several recent insider sales were disclosed by executives, including the CEO, COO, and general counsel. The company said some of the selling was tied to pre-arranged trading plans and tax withholding on equity vesting, which limits the signal as a fundamental warning.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in ALAB. Atreides Management LP lifted its stake in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock worth $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock worth $2,690,907,000 after buying an additional 1,693,918 shares in the last quarter. Amundi lifted its stake in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company's stock worth $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC bought a new position in shares of Astera Labs in the third quarter worth approximately $209,599,000. Finally, BNP Paribas Financial Markets raised its holdings in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company's stock valued at $220,733,000 after purchasing an additional 960,899 shares during the last quarter. Institutional investors own 60.47% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the stock. Roth Mkm reissued a "buy" rating and set a $275.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Evercore reissued an "outperform" rating and set a $297.00 price objective on shares of Astera Labs in a research note on Tuesday. UBS Group assumed coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They set a "neutral" rating and a $180.00 price objective on the stock. Morgan Stanley boosted their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 6th. Finally, Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a "neutral" rating and a $153.00 price objective on the stock. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $233.75.
Get Our Latest Research Report on ALAB
About Astera Labs
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
